Filing Flows › Adia Med (ADIA) › Q2 2026
Adia Med (ADIA) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
Adia Med (ADIA) reported revenue of $485K for the second quarter 2026 (Q2 2026), +311% from a year earlier and +175% from the quarter before. Operating margin was 10.7%, net earnings $40K (8.3% of revenue).
Adia Med, Q2 2026: revenue $485K (+311% year over year), operating margin 10.7%, net earnings $40K, operating cash flow −$109K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $485K | +175% | +311% |
| Gross profit | $283K | +318% | +990% |
| Operating profit | $52K | — | — |
| Net earnings | $40K | — | — |
| Operating cash flow | −$109K | — | — |
What changed
Revenue was $485K in Q2 2026, up 311% year over year and up 175% from the previous quarter. Medical Procedures was the largest line at 68% of revenue. Medical Procedures added $304K year over year (up 1169%), 83% of the total change.
Gross margin was 58.2%, up 36.3 points from a year earlier. Operating profit was $52K, a 10.7% margin (up 109.4 points year over year). Operating expenses grew 62% against revenue growth of 311%. Net earnings were $40K. The effective tax rate was 0.0%.
Operating cash flow was −$109K. Non-cash charges added back $1K of depreciation. Working capital and other items used $151K. Capital expenditures of $0K exceeded it, leaving free cash flow of −$109K.
Questions
What was Adia Med's revenue in the second quarter 2026?
Adia Med (ADIA) reported revenue of $485K for the second quarter 2026 (Q2 2026), +311% from a year earlier and +175% from the quarter before.
Was Adia Med profitable in the second quarter 2026?
Operating profit was $52K (10.7% of revenue) and net earnings $40K.
Source: Adia Med 10-Q on SEC EDGAR.